The CABI Trial: an Unblinded Parallel Group Randomised Controlled Feasibility Trial of Long-Course Antibiotic Therapy (28 Days) Compared with Short Course (≤ 10 Days) in the Prevention of Relapse in Adults Treated for Complicated Intra-Abdominal Infection.
Shadia AhmedRory BrownRichard PettingerArmando Vargas-PalaciosDermot BurkeAndrew KirbyPublished in: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract (2020)
ClinicalTrials.gov Identifier: NCT03265834.